Proud of Campus researcher Cisca Wijmenga; Winner Spinoza Prize 2015!

Friday 12 June 2015

Print this page
Announcement; winner of the Spinoza Prize 2015
Announcement; winner of the Spinoza Prize 2015

Cisca Wijmenga, professor of human genetics, one of the winners of the Spinoza Prize 2015. She receives the most important Dutch research prize especially for her work to unravel the genetic basis of gluten intolerance (celiac disease). The prize consists of 2.5 million that she can spend freely on research.

'What happens to me now is amazing' responds Wijmenga.  'But I sincerely hope that this is a boost for more serious attention to gluten intolerance. This may benefit many patients enormously.'

‘It is a huge honour and recognition of the work that our group has been doing for the past 20 years,’ says Professor Wijmenga. The genetics of gluten intolerance has always been at the forefront of her research work. ‘We knew nothing about it when I started, now we have identified about half the DNA sites which play a part in the development of this disease.’

Cisca Wijmenga, professor of human genetics, winner of Spinoza Prize 2015
Cisca Wijmenga, professor of human genetics, winner of Spinoza Prize 2015

NWO Spinoza Prize

The NWO Spinoza prize is the highest award in the Netherlands science arena and can be seen as the ‘Dutch Nobel Prize’. Each year, NWO awards Spinoza prizes to three or four researchers working in the Netherlands who, according to international standards, belong at the very top of their scientific field. NWO Spinoza laureates perform ground-breaking research that has a major impact and they are a source of inspiration to younger researchers. The prize winners will each receive €2.5 million to spend on scientific research. In this way NWO stimulates top research work in the Netherlands.

Confirmation of theory after 10 years
It appears that cells in the immune system become overactive in patients with coeliac disease. It confirms a theory put forward by Wijmenga some ten years ago: that the basis for coeliac disease may be common to other autoimmune diseases, like rheumatism, multiple sclerosis and Crohn’s disease. ‘It could mean that a treatment which works for one of these diseases would also be suitable for other autoimmune diseases.’

Recognition for thousands of patients
It is a matter of patience, however, to make progress in the study of coeliac disease. ‘The impact on the daily lives of patients is still small. It could easily be another twenty years before this type of research leads to a specific treatment.’ Professor Wijmenga sees the Spinoza Prize also as recognition for the thousands of patients who have taken part in her research. ‘My dream is that one day there will be a simple test for coeliac disease. At the moment seven out of eight patients suffering from the disease don’t even realize that they have it.’

The condition causes general symptoms, such as tiredness. ‘Sometimes we discover coeliac disease in family members of patients who themselves report that they have no problems. They think that tiredness is simply part of their lives.’ Once on a gluten-free diet they often see a huge improvement.

The Dutch Genome
Cisca Wijmenga is investigating the link between genetics and health in other projects too. For example, she led the national ‘Het genoom van Nederland’ (The Dutch genome) project which analyzed the DNA of 250 groups of three, comprising two parents and one child. One surprising outcome was that many people turned out to have pathogenic mutations but had not become sick.

‘Then you want to know why some people do get sick and others don’t,’ Wijmenga says. The Groningen project Lifelines offers an ideal way of investigating that. Groningen researchers have been following the health of 167,000 people living in the three northern provinces of the Netherlands. This will show which people with a genetic risk do actually become sick.

No shortage of ideas
Professor Wijmenga will reveal how she intends to spend the € 2.5 million when the prize is presented on 14 September. ‘That’s something I will be carefully thinking about over the summer.’ There is no shortage of ideas. ‘Using Lifelines to determine the root causes of coeliac disease, for example.  But I am also thinking of research on medical therapies that are specifically geared to the genetic profile and other aspects of the patient, personalized medicine.’

She emphasizes that the Spinoza Prize is also important for keeping her research group going. ‘I mainly set the parameters. The young people in the lab do most of the work. This prize money means that I can give them room to develop further and become independent researchers.’

Curriculum vitae
Cisca Wijmenga (1964) has been Professor of Human Genetics at the University Medical Center Groningen and the University of Groningen since 2007. Prior to that she was a professor at the University of Utrecht. She studied biology at the University of Groningen and was awarded her PhD cum laude by the University of Leiden in 1993. During the early years of her career she became fascinated by the vast amount of information held in DNA. She worked also as a postdoc in the laboratory of the American geneticist Francis Collins, who at the time was leading the Human Genome Project, the consortium that was the first to decipher the human genome.

As Head of the Department of Genetics she leads a team of about 250 people working in the clinic and in research. She has authored or co-authored more than 400 scientific papers that have been cited more than 27,000 times. She was appointed member of the KNAW (Royal Netherlands Academy of Arts and Sciences) in 2012.